NCI (NCIT) Awarded National Institute of Health’s CIO-SP3 GWAC with $20B Ceiling

NCI, Inc. (NASDAQ:NCIT), a leading provider of information technology (IT) and professional services and solutions to U.S. Federal Government agencies, announced today that it was an awardee on the $20B ceiling Chief Information Officers-Solutions and Partners (CIO-SP3) Government Wide Acquisition Contract (GWAC). The National Institutes of Health (NIH) Information Technology Acquisition and Assessment Center (NITAAC) posted the awards. The broad-based IT contract focuses on health and biomedical-related IT services, with a period of performance is 10 years, and representing new business for NCI.

Under the contract, NCI is eligible to compete for task orders in ten functional areas including Healthcare IT Services, Chief Information Officer (CIO) Support, Imaging, Outsourcing, IT Operations and Maintenance, Integration Services, Government Outsourcing, Critical Infrastructure Protection and Information Assurance, Digital Government, Enterprise Management Systems, and Software Development. CIO-SP3 is a successor to the highly successful CIO-SP2i and the Image World2 New Dimensions GWACs.

“NCI is delighted to have been awarded the CIO-SP3 contract. This award enables NCI and its large and small business teammates to provide a wide array of innovative solutions in health IT and other functional areas to NIH and other federal agencies. The award further expands our portfolio of major prime GWAC, IDIQ and other multiple-award vehicles, particularly in the area of federal health IT,” said NCI’s President, Brian Clark.

About NCI, Inc.:

NCI is a leading provider of IT and professional services and solutions to U.S. Federal Government agencies. NCI’s award-winning expertise encompasses areas critical to its customers’ mission objectives, including enterprise systems management; network engineering; cybersecurity and information assurance; software development and systems engineering; program management, acquisition, and lifecycle support; engineering and logistics; health IT and informatics; and training and simulation. The company is a member of the Russell 2000 and S&P Small Cap 600 indexes. Headquartered in Reston, VA, NCI has approximately 2,300 employees at more than 100 locations worldwide. For more information, visit our website at www.nciinc.com, or email mcrystal@nciinc.com.

Forward-Looking Statement: Statements and assumptions made in this press release, which do not address historical facts, constitute “forward-looking” statements that NCI, Inc. believes to be within the definition in the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties, many of which are outside of our control. Such forward-looking statements are subject to factors that could cause actual results to differ materially from those anticipated results. These factors include but are not limited to: the failure of the Government to allot funds to NCI to complete performance of the contract; the risk of contract performance; government contract procurement (such as bid protest) and termination risks; competitive factors such as pricing pressures and/or competition to hire and retain employees; and material changes in laws or regulations applicable to the company’s businesses. For a discussion of these and other risks and uncertainties, please refer to the section titled “Risk Factors” in the NCI, Inc. Form 10-K filed with the Securities and Exchange Commission for the period ended December 31, 2011. The forward-looking statements included in this news release are only made as of the date of this news release and NCI, Inc. undertakes no obligation to publicly update any of the forward-looking statements made herein, whether as a result of new information, subsequent events or circumstances, changes in expectations or otherwise.